Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $2.6 million.

  • Cryo Cell International's Accounts Payables rose 3056.01% to $2.6 million in Q3 2025 from the same period last year, while for Aug 2025 it was $2.6 million, marking a year-over-year increase of 3056.01%. This contributed to the annual value of $1.9 million for FY2024, which is 4070.8% down from last year.
  • Latest data reveals that Cryo Cell International reported Accounts Payables of $2.6 million as of Q3 2025, which was up 3056.01% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Cryo Cell International's Accounts Payables peaked at $4.1 million during Q2 2023, and registered a low of $860132.0 during Q1 2021.
  • Its 5-year average for Accounts Payables is $2.1 million, with a median of $1.9 million in 2024.
  • In the last 5 years, Cryo Cell International's Accounts Payables skyrocketed by 13547.86% in 2023 and then plummeted by 5494.06% in 2024.
  • Cryo Cell International's Accounts Payables (Quarter) stood at $1.5 million in 2021, then grew by 7.75% to $1.6 million in 2022, then surged by 97.76% to $3.2 million in 2023, then plummeted by 40.71% to $1.9 million in 2024, then surged by 38.76% to $2.6 million in 2025.
  • Its Accounts Payables stands at $2.6 million for Q3 2025, versus $2.2 million for Q2 2025 and $2.7 million for Q1 2025.